Edition:
India

Integra LifeSciences Holdings Corp (IART.OQ)

IART.OQ on NASDAQ Stock Exchange Global Select Market

66.68USD
1:30am IST
Change (% chg)

$0.06 (+0.09%)
Prev Close
$66.62
Open
$66.65
Day's High
$66.93
Day's Low
$66.29
Volume
227,449
Avg. Vol
293,307
52-wk High
$67.43
52-wk Low
$43.04

Chart for

About

Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing, and marketing of surgical implants and medical instruments. Its segments include Specialty Surgical Solutions, which offers specialty surgical instrumentation for a range of specialties, including... (more)

Overall

Beta: 0.66
Market Cap(Mil.): $4,021.81
Shares Outstanding(Mil.): 78.08
Dividend: --
Yield (%): --

Financials

BRIEF-Integra Lifesciences Prices Public Offering Of Common Stock

* INTEGRA LIFESCIENCES PRICES PUBLIC OFFERING OF COMMON STOCK

10 May 2018

BRIEF-Integra LifeSciences Announces Proposed Public Offering Of Common Stock

* INTEGRA LIFESCIENCES ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

10 May 2018

BRIEF-Integra Lifesciences Announces Amendment And Extension Of Credit Facility

* INTEGRA LIFESCIENCES ANNOUNCES AMENDMENT AND EXTENSION OF CREDIT FACILITY

08 May 2018

BRIEF-Integra Lifesciences Reports Q1 Adjusted Earnings Per Share $0.58

* INTEGRA LIFESCIENCES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

25 Apr 2018

BRIEF-Integra LifeSciences Says CEO's 2017 Compensation Was $7.1 Mln

* INTEGRA LIFESCIENCES HOLDINGS CORP SAYS CEO PETER J. ARDUINI'S 2017 TOTAL COMPENSATION WAS $7.1 MILLION VERSUS $7 MILLION IN 2016 – SEC FILING ‍​ Source: (https://bit.ly/2HdNFnd) Further company coverage:

06 Apr 2018

BRIEF-Integra Lifesciences Holdings Reports Q4 EPS Of $0.56

* INTEGRA LIFESCIENCES REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

27 Feb 2018

BRIEF-Integra Lifesciences Q4 Adjusted Earnings Per Share $0.64

* INTEGRA LIFESCIENCES REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS

27 Feb 2018

BRIEF-Integra Lifesciences Announces Preliminary Q4 Earnings Per Share View $0.55, Revenue View $351.0

* - ‍ORGANIC REVENUE GROWTH IN Q4 IS EXPECTED TO BE ABOUT 5.5%, ABOVE COMPANY'S IMPLIED GUIDANCE OF ABOUT 4%​

08 Jan 2018

Earnings vs. Estimates